Covered recipient · General Payments record
ALOK BHAGAT
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$5,221.49
- Reported across 315 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $656.33 | 32 |
| Education | $33.44 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $154.41 | 9 |
| Lundbeck LLC | $81.05 | 3 |
| EISAI INC. | $72.04 | 3 |
| Alexion Pharmaceuticals, Inc. | $63.69 | 2 |
| Celgene Corporation | $59.67 | 4 |
| Biogen, Inc. | $48.55 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $35.48 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $33.44 | 2 |
| ABBVIE INC. | $29.78 | 2 |
| JAZZ PHARMACEUTICALS INC. | $25.99 | 1 |
| Neurocrine BioSciences, Inc. | $24.86 | 1 |
| SK Life Science, Inc. | $23.59 | 1 |
| EMD Serono, Inc. | $23.13 | 1 |
| HARMONY BIOSCIENCES LLC | $14.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.95 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319606 | CMS |
| ABBVIE INC. | $15.83 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319608 | CMS |
| Alexion Pharmaceuticals, Inc. | $26.67 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093917844 | CMS |
| Alexion Pharmaceuticals, Inc. | $37.02 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093917624 | CMS |
| Biogen, Inc. | $24.65 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104871550 | CMS |
| Biogen, Inc. | $23.90 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104872758 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 10/31/2024 | Education | Undisputed | 01/23/2026 | 1144442944 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 12/03/2024 | Education | Undisputed | 01/23/2026 | 1144442946 | CMS |
| Celgene Corporation | $16.45 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101177454 | CMS |
| Celgene Corporation | $14.92 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101177468 | CMS |
| Celgene Corporation | $13.15 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101177472 | CMS |
| Celgene Corporation | $15.15 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101177478 | CMS |
| Eisai Inc. | $22.76 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110728301 | CMS |
| Eisai Inc. | $18.81 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110728303 | CMS |
| Eisai Inc. | $30.47 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110728305 | CMS |
| EMD Serono, Inc. | $23.13 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120251920 | CMS |
| HARMONY BIOSCIENCES LLC | $14.09 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126085709 | CMS |
| JAZZ PHARMACEUTICALS INC. | $25.99 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150220294 | CMS |
| Lundbeck LLC | $34.05 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145897254 | CMS |
| Lundbeck LLC | $22.38 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145897256 | CMS |
| Lundbeck LLC | $24.62 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145897258 | CMS |
| Neurocrine Biosciences, Inc. | $24.86 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150840324 | CMS |
| Novartis Pharmaceuticals Corporation | $16.80 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086691079 | CMS |
| Novartis Pharmaceuticals Corporation | $18.68 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086691081 | CMS |
| SK Life Science, Inc. | $23.59 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154120817 | CMS |
| UCB, Inc. | $16.81 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143445019 | CMS |
| UCB, Inc. | $16.27 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143445024 | CMS |
| UCB, Inc. | $15.05 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143445028 | CMS |
| UCB, Inc. | $16.11 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143445033 | CMS |
| UCB, Inc. | $16.79 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143445037 | CMS |
| UCB, Inc. | $19.33 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143445042 | CMS |
| UCB, Inc. | $13.81 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143445046 | CMS |
| UCB, Inc. | $22.55 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143445050 | CMS |
| UCB, Inc. | $17.69 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143497385 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.